Standout Papers

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis 2010 2026 2015 2020 1.6k
  1. Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis (2010)
    Jeffrey A. Cohen, Frederik Barkhof et al. New England Journal of Medicine
  2. Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial (2014)
    Peter A. Calabresi, Ernst-Wilhelm Radüe et al. The Lancet Neurology

Immediate Impact

1 by Nobel laureates 17 from Science/Nature 82 standout
Sub-graph 1 of 19

Citing Papers

Neutrophil Membrane‐Camouflaged Polyprodrug Nanomedicine for Inflammation Suppression in Ischemic Stroke Therapy
2024 Standout
IL-10 constrains sphingolipid metabolism to limit inflammation
2024 StandoutNature
16 intermediate papers

Works of Tracy Stites being referenced

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
2014 Standout
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
2010 Standout

Author Peers

Author Last Decade Papers Cites
Tracy Stites 2280 1521 126 827 21 3.3k
Lixin Zhang-Auberson 1983 1251 51 695 13 2.7k
Shreeram Aradhye 1469 1767 113 480 22 3.2k
Katherine Dawson 2238 889 112 750 32 3.4k
Gavin Giovannoni 3311 714 136 1114 17 4.4k
Matvey Lukashev 523 1531 38 169 21 3.6k
Lee Honigberg 786 1286 138 96 42 3.4k
Anna Schubart 828 1224 24 224 38 4.0k
JC Reed 849 3949 23 139 31 5.9k
Barbara Serafini 4014 944 106 1297 52 7.1k
Martin van der Valk 618 3942 49 381 45 6.8k

All Works

Loading papers...

Rankless by CCL
2026